The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

"Devyn brings a rare combination of scientific depth, operational leadership, and strategic perspective," said Nazli Azimi, Ph.D., Chief Executive Officer of Therna. "His experience across genetic ...

Abstract: Machine translation and post-editing (MTPE) in the language service industry is widely recognized with the development of machine translation (MT) technology and the increase in global ...

Learn more about the cutting-edge technology that enables 3D printing inside living cells and what that means for the ...

New six-part webinar series on genetic causes of cerebral palsy launches Wednesday We are excited to partner with ...

"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...

The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first.

The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay ...

Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...